Articles by Kerri Fitzgerald
A phase I study presented at the American Association of Clinical Research Annual Meeting showed that chimeric antigen ...
The U.S. Food and Drug Administration approved Retevmo® (selpercatinib) for three types of RET-mutated cancer: adults ...
The U.S. Food and Drug Administration (FDA) approved Tabrecta™ (capmatinib) for adults with metastatic non-small cell ...
Frontline tislelizumab plus chemotherapy significantly improved progression-free survival (primary endpoint) compared ...
A study published in Thorax found that patients with chronic obstructive pulmonary disease (COPD) who have never smoked ...
The U.S. Food and Drug Administration approved Imfinzi® (durvalumab) in combination with etoposide plus either ...
The U.S. Food and Drug Administration approved Tecentriq® (atezolizumab) in combination with Abraxane® (paclitaxel) ...
Air pollution is linked to nine specific causes of death, including lung cancer, according to a study published in JAMA ...
In the past decade, new lung cancer cases have decreased by 19% and five-year survival has increased by 26%, according ...
Men who are current or former smokers who have higher cardiorespiratory fitness may be less likely to develop lung ...
Frontline Tagrisso® Improves Survival Compared With Other Tyrosine Kinase Inhibitors for Lung Cancer
First-line Tagrisso® (osimertinib) improved overall survival (OS) compared with a comparator tyrosine kinase inhibitor ...
The U.S. Food and Drug Administration (FDA) granted breakthrough therapy designation to the oral MET inhibitor tepotinib ...
Pooled data from two clinical trials showed that nivolumab (Opdivo®) resulted in a fivefold increase in five-year ...
The experimental drug LOXO-292 (now called selpercatinib) shrank tumors in nearly 70% of lung tumors with the ...
A phase I/II study published in JAMA Oncology found that the HIV protease inhibitor Viracept® (nelfinavir mesylate) ...
A phase I/Ib study published in Clinical Cancer Research found that treatment with the immune checkpoint inhibitor ...
The U.S. Food and Drug Administration (FDA) approved atezolizumab in combination with carboplatin and etoposide for ...
A study published in The Annals of Thoracic Surgery indicated that smoking cessation any time prior to surgery for ...
The U.S. Food and Drug Administration approved atezolizumab in combination with bevacizumab, carboplatin, and ...
U.S. lung cancer mortality is projected to decrease by 79% by 2065, according to a comparative model study ...
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.